STERIS Statistics
Total Valuation
STERIS has a market cap or net worth of $24.33 billion. The enterprise value is $26.12 billion.
| Market Cap | 24.33B |
| Enterprise Value | 26.12B |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Sep 4, 2025 |
Share Statistics
STERIS has 98.49 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Current Share Class | 98.49M |
| Shares Outstanding | 98.49M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 94.15% |
| Float | 98.11M |
Valuation Ratios
The trailing PE ratio is 37.78 and the forward PE ratio is 23.97.
| PE Ratio | 37.78 |
| Forward PE | 23.97 |
| PS Ratio | 4.37 |
| Forward PS | 4.07 |
| PB Ratio | 3.50 |
| P/TBV Ratio | 26.55 |
| P/FCF Ratio | 26.78 |
| P/OCF Ratio | 19.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.36, with an EV/FCF ratio of 28.74.
| EV / Earnings | 40.40 |
| EV / Sales | 4.69 |
| EV / EBITDA | 17.36 |
| EV / EBIT | 25.60 |
| EV / FCF | 28.74 |
Financial Position
The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.30.
| Current Ratio | 2.22 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | 2.28 |
| Interest Coverage | 14.22 |
Financial Efficiency
Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 7.13%.
| Return on Equity (ROE) | 9.74% |
| Return on Assets (ROA) | 6.22% |
| Return on Invested Capital (ROIC) | 7.13% |
| Return on Capital Employed (ROCE) | 10.77% |
| Revenue Per Employee | $313,213 |
| Profits Per Employee | $36,355 |
| Employee Count | 17,787 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 4.63 |
Taxes
In the past 12 months, STERIS has paid $203.25 million in taxes.
| Income Tax | 203.25M |
| Effective Tax Rate | 23.83% |
Stock Price Statistics
The stock price has increased by +5.61% in the last 52 weeks. The beta is 0.92, so STERIS's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +5.61% |
| 50-Day Moving Average | 234.52 |
| 200-Day Moving Average | 224.83 |
| Relative Strength Index (RSI) | 67.17 |
| Average Volume (20 Days) | 693,046 |
Short Selling Information
The latest short interest is 987,828, so 1.00% of the outstanding shares have been sold short.
| Short Interest | 987,828 |
| Short Previous Month | 819,338 |
| Short % of Shares Out | 1.00% |
| Short % of Float | 1.01% |
| Short Ratio (days to cover) | 1.52 |
Income Statement
In the last 12 months, STERIS had revenue of $5.57 billion and earned $646.64 million in profits. Earnings per share was $6.53.
| Revenue | 5.57B |
| Gross Profit | 2.47B |
| Operating Income | 1.02B |
| Pretax Income | n/a |
| Net Income | 646.64M |
| EBITDA | 1.50B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | $6.53 |
Balance Sheet
The company has $279.70 million in cash and $2.07 billion in debt, giving a net cash position of -$1.79 billion or -$18.17 per share.
| Cash & Cash Equivalents | 279.70M |
| Total Debt | 2.07B |
| Net Cash | -1.79B |
| Net Cash Per Share | -$18.17 |
| Equity (Book Value) | 6.97B |
| Book Value Per Share | 70.63 |
| Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was $1.26 billion and capital expenditures -$355.59 million, giving a free cash flow of $908.80 million.
| Operating Cash Flow | 1.26B |
| Capital Expenditures | -355.59M |
| Free Cash Flow | 908.80M |
| FCF Per Share | $9.23 |
Margins
Gross margin is 44.38%, with operating and profit margins of 18.32% and 11.61%.
| Gross Margin | 44.38% |
| Operating Margin | 18.32% |
| Pretax Margin | 15.31% |
| Profit Margin | 11.61% |
| EBITDA Margin | 27.01% |
| EBIT Margin | 18.32% |
| FCF Margin | 16.31% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | 9.86% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 44.57% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 1.41% |
| Earnings Yield | 2.66% |
| FCF Yield | 3.73% |
Analyst Forecast
The average price target for STERIS is $268.25, which is 8.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $268.25 |
| Price Target Difference | 8.57% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 6.51% |
| EPS Growth Forecast (5Y) | 15.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
STERIS has an Altman Z-Score of 5.24 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.24 |
| Piotroski F-Score | 7 |